Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -4,375 More Arrow -3,970 More Arrow -3,660
EBITDA -4,395 More Arrow -3,981 More Arrow -3,659
Total assets 1,657 More Arrow 2,412 More Arrow 3,296
Current assets 1,513 More Arrow 2,245 More Arrow 3,024
Current liabilities 463 More Arrow 716 Less Arrow 586
Equity capital 1,194 More Arrow 1,696 More Arrow 2,710
- share capital 768 Less Arrow 517 Less Arrow 230
Employees (average) 4 Equal arrow 4 More Arrow 5

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 72.1% Less Arrow 70.3% More Arrow 82.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -264.0% More Arrow -164.6% More Arrow -111.0%
Current ratio 326.8% Less Arrow 313.5% More Arrow 516.0%
Return on equity (ROE) -366.4% More Arrow -234.1% More Arrow -135.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -1 More Arrow 0
Chg. No. of employees % 0% Less Arrow -20% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.